Citations

Mayo Clinic

Showing 10 of 108551 citations.

Moderate Traumatic Brain Injury in Adult Population: The Latin American Brain Injury Consortium Consensus for Definition and Categorization
Godoy, Daniel Agustín , Jibaja, Manuel, Videtta, Walter , Rovegno, Maximiliano , Paranhos, Jorge Luiz da Rocha, Paranhos, Eduardo, Amorim, Robson Luís Oliveira de , Filho, Ruy Castro Monteiro da Silva, Flecha, Jorge, Faleiro, Rodrigo Moreira , Almanza, David, Rodrı́guez, Eliana , Carrizosa, Jorge , Rubiano, Andrés M. , Aguilera, Sergio, Paiva, Wellingson Silva , Rodriguez, Eliana, Hawryluk, Gregory W. J. , Rabinstein, Alejandro A.

Neurosurgery | March 26, 2024 | Volume: 95 | Issue: 3 | Pages: e57-e70

10.1227/neu.0000000000002912 | PMID 38529956 Get It

Moderate traumatic brain injury (TBI) is a diagnosis that describes diverse patients with heterogeneity of primary injuries. Defined by a Glasgow Coma Scale between 9 and 12, this category includes patients who may neurologically worsen and require increasing intensive care resources and/or emergency neurosurgery. Despite the unique characteristics of these patients, there have not been specific guidelines published before this effort to support decision-making in these patients. A Delphi consensus group from the Latin American Brain Injury Consortium was established to generate recommendations related to the definition and categorization of moderate TBI. Before an in-person meeting, a systematic review of the literature was performed identifying evidence relevant to planned topics. Blinded voting assessed support for each recommendation. A priori the threshold for consensus was set at 80% agreement. Nine PICOT questions were generated by the panel, including definition, categorization, grouping, and diagnosis of moderate TBI. Here, we report the results of our work including relevant consensus statements and discussion for each question. Moderate TBI is an entity for which there is little published evidence available supporting definition, diagnosis, and management. Recommendations based on experts' opinion were informed by available evidence and aim to refine the definition and categorization of moderate TBI. Further studies evaluating the impact of these recommendations will be required.
Downregulation of protein phosphatase 2Aα in asthmatic airway smooth muscle
Reza, Mohammad Irshad , Pabelick, Christina M. , Britt, Rodney D. , Prakash, Y. S. , Sathish, Venkatachalem , Kumar, Ashish , Pabelick, Christina M , Britt, Rodney D , Prakash, Y S , Sathish, Venkatachalem , Kumar, Ashish

American Journal of Physiology-Lung Cellular and Molecular Physiology | March 26, 2024 | Volume: 326 | Issue: 5 | Pages: L651-L659

10.1152/ajplung.00050.2024 | PMID 38529552 Get It

This novel study deciphered the expression and function of protein phosphatase 2Aα (PP2Aα) in airway smooth muscle (ASM) during asthma and/or inflammation. We showed robust expression of PP2Aα in human ASM while its downregulation in asthmatic ASM. Similarly, we demonstrated reduced PP2Aα expression in ASM exposed to proinflammatory cytokines. PP2Aα activation inhibited bronchoconstriction of isolated mouse bronchi. In addition, we unveiled that PP2Aα activation inhibits the intracellular calcium release and myosin light chain phosphorylation in human ASM.
Premorbid body weight predicts weight loss in both anorexia nervosa and atypical anorexia nervosa: Further support for a single underlying disorder
Hebebrand, Johannes , Seitz, Jochen , Föcker, Manuel , Viersen, Hanna Preuss‐van , Huß, Michael , Bühren, Katharina , Dahmen, Brigitte , Becker, Katja , Weber, Linda , Jaite, Charlotte , Romanos, Marcel , Seidel, Maria , Fleischhaker, Christian , Möhler, Eva , Hahn, Freia , Hagmann, Daniela , Renner, Tobias , Schulze, Ulrike , Thiemann, Ulf , Antony, Gisela , Matthews, Abigail , Peters, Triinu , Correll, Christoph Ulrich , Jaite, Charlotte , Egberts, Karin , Romanos, Marcel , Ehrlich, Stefan , Seidel, Maria , Roessner, Veit , Fleischhaker, Christian , Möhler, Eva , Hahn, Freia , Kaess, Michael , Legenbauer, Tanja , Hagmann, Daniela , Renner, Tobias J , Schulze, Ulrike M E , Thiemann, Ulf , Wessing, Ida , Antony, Gisela , Herpertz-Dahlmann, Beate , Matthews, Abigail , Peters, Triinu , Viersen, Hanna Preuss‐van , Egberts, Karin , Ehrlich, Stefan

International Journal of Eating Disorders | March 26, 2024 | Volume: 57 | Issue: 4 | Pages: 967-982

10.1002/eat.24189 | PMID 38528714 Get It

Abstract Objective For adolescents, DSM‐5 differentiates anorexia nervosa (AN) and atypical AN with the 5th BMI‐centile‐for‐age. We hypothesized that the diagnostic weight cut‐off yields (i) lower weight loss in atypical AN and (ii) discrepant premorbid BMI distributions between the two disorders. Prior studies demonstrate that premorbid BMI predicts admission BMI and weight loss in patients with AN. We explore these relationships in atypical AN. Method Based on admission BMI‐centile < or ≥5th, participants included 411 female adolescent inpatients with AN and 49 with atypical AN from our registry study. Regression analysis and t ‐tests statistically addressed our hypotheses and exploratory correlation analyses compared interrelationships between weight loss, admission BMI, and premorbid BMI in both disorders. Results Weight loss in atypical AN was 5.6 kg lower than in AN upon adjustment for admission age, admission height, premorbid weight and duration of illness. Premorbid BMI‐standard deviation scores differed by almost one between both disorders. Premorbid BMI and weight loss were strongly correlated in both AN and atypical AN. Discussion Whereas the weight cut‐off induces discrepancies in premorbid weight and adjusted weight loss, AN and atypical AN overall share strong weight‐specific interrelationships that merit etiological consideration. Epidemiological and genetic associations between AN and low body weight may reflect a skewed premorbid BMI distribution. In combination with prior findings for similar psychological and medical characteristics in AN and atypical AN, our findings support a homogenous illness conceptualization. We propose that diagnostic subcategorization based on premorbid BMI, rather than admission BMI, may improve clinical validity. Public significance Because body weights of patients with AN must drop below the 5th BMI‐centile per DSM‐5, they will inherently require greater weight loss than their counterparts with atypical AN of the same sex, age, height and premorbid weight. Indeed, patients with atypical AN had a 5.6 kg lower weight loss after controlling for these variables. In comparison to the reference population, we found a lower and higher mean premorbid weight in patients with AN and atypical AN, respectively. Considering previous psychological and medical comparisons showing little differences between AN and atypical AN, we view a single disorder as the most parsimonious explanation. Etiological models need to particularly account for the strong relationship between weight loss and premorbid body weight.
Plasma glial fibrillary acidic protein in the visual and language variants of Alzheimer's disease
Sintini, Irene , Singh, Neha Atulkumar , Li, Danni , Jack, Clifford R. , Lowe, Val J. , Graff‐Radford, Jonathan , Josephs, Keith A. , Whitwell, Jennifer L. , Jack, Clifford R , Singh, Neha Atulkumar , Mielke, Michelle M. , Machulda, Mary M. , Schwarz, Christopher G. , Senjem, Matthew L.

Alzheimer's & Dementia | March 26, 2024 | Volume: 20 | Issue: 5 | Pages: 3679-3686

10.1002/alz.13713 | PMID 38528318 Get It

AbstractINTRODUCTIONGlial fibrillary acidic protein (GFAP) in plasma is a proxy for astrocytic activity and is elevated in amyloid‐β (Aβ)‐positive individuals, making GFAP a potential blood‐based biomarker for Alzheimer's disease (AD).METHODSWe assessed plasma GFAP in 72 Aβ‐positive participants diagnosed with the visual or language variant of AD who underwent Aβ‐ and tau‐PET. Fifty‐nine participants had follow‐up imaging. Linear regression was applied on GFAP and imaging quantities.RESULTSGFAP did not correlate with Aβ‐ or tau‐PET cross‐sectionally. There was a limited positive correlation between GFAP and rates of tau accumulation, particularly in the language variant of AD, although associations were weaker after removing one outlier patient with the highest GFAP level.DISCUSSIONAmong Aβ‐positive AD participants with atypical presentations, plasma GFAP did not correlate with levels of AD pathology on PET, suggesting that the associations between GFAP and AD pathology might plateau during the advanced phase of the disease.
Implementation of a pharmacy technician career ladder and pharmacy technician training program
Thames, Lisa, Johnston, C. J., Cash, Julie, Holder, Martina, Voils, Alissa , Johnston, Corry, Johnston, Corry, Voils, Alissa

American Journal of Health-System Pharmacy | March 25, 2024 | Volume: 81 | Issue: 15 | Pages: e437-e442

10.1093/ajhp/zxae063 | PMID 38530790 Get It

Abstract Purpose To describe the implementation of a pharmacy technician career ladder and internal technician training program at UF Health Shands Hospital in Gainesville, FL. Summary As the systems for providing care and receiving reimbursement become more complex, the ability to deliver comprehensive care in the most efficient and effective manner is critical. In order to maximize impact, pharmacists must practice at the top of their license. Recruitment and retention practices that support an optimized pharmacy technician workforce and continued expansion of technician roles are vital to advancement of pharmacy practice. This report describes the efforts to improve technician recruitment, professional development, and retention through the implementation of a technician career ladder and internal training program. The programs contributed to a reduction in technician rolling 12-month turnover rates from 26.72% in July 2015 to 13.1% in March 2023 (a reduction of 51%). Overtime hours as a percentage of total hours worked were reduced from 11.02% in July 2015 to 4.54% in March 2023 (a reduction of 59%). Improvements were noted in pharmacy technician job satisfaction, as evidenced by key employee engagement indicators including responses to the posed statement “Overall, I am a satisfied employee,” with a mean score of 3.32 (on a scale of 1-5) in 2015 as compared to 4.2 in 2019 (a 21% increase). Conclusion Implementation of a pharmacy technician career ladder and technician training program creates a sustainable and effective recruitment and retention pathway that may favorably impact technician job satisfaction, turnover, and career development opportunities.
Brain morphometry in former American football players: findings from the DIAGNOSE CTE research project
Arciniega, Hector , Baucom, Zachary, Tuz‐Zahra, Fatima , Tripodis, Yorghos , John, Omar , Carrington, Holly , Knyazhanskaya, Evdokiya , Jung, Leonard , Breedlove, Katherine M. , Wiegand, Tim L. T. , Daneshvar, Daniel H. , Rushmore, R. Jarrett , Billah, Tashrif , Pasternak, Ofer , Coleman, Michael J. , Bernick, Charles , Balcer, Laura J. , Alosco, Michael L. , Lin, Alexander , Reiman, Eric M. , Shenton, Martha E. , Jung, Leonard B , Breedlove, Katherine , Alosco, Michael L , Koerte, Inga K , Tripodis, Yorghos , Daneshvar, Daniel H , Shenton, Martha E , Arciniega, Hector , Kim, Nicholas , Adler, Charles H. , Cummings, Jeffrey L. , Stern, Robert A. , Bouix, Sylvain

Brain | March 25, 2024 | Volume: 147 | Issue: 10 | Pages: 3596-3610

10.1093/brain/awae098 | PMID 38533783 Get It

Abstract Exposure to repetitive head impacts in contact sports is associated with neurodegenerative disorders including chronic traumatic encephalopathy (CTE), which currently can be diagnosed only at post-mortem. American football players are at higher risk of developing CTE given their exposure to repetitive head impacts. One promising approach for diagnosing CTE in vivo is to explore known neuropathological abnormalities at post-mortem in living individuals using structural MRI. MRI brain morphometry was evaluated in 170 male former American football players ages 45–74 years (n = 114 professional; n = 56 college) and 54 same-age unexposed asymptomatic male controls (n = 54, age range 45–74). Cortical thickness and volume of regions of interest were selected based on established CTE pathology findings and were assessed using FreeSurfer. Group differences and interactions with age and exposure factors were evaluated using a generalized least squares model. A separate logistic regression and independent multinomial model were performed to predict each traumatic encephalopathy syndrome (TES) diagnosis, core clinical features and provisional level of certainty for CTE pathology using brain regions of interest. Former college and professional American football players (combined) showed significant cortical thickness and/or volume reductions compared to unexposed asymptomatic controls in the hippocampus, amygdala, entorhinal cortex, parahippocampal gyrus, insula, temporal pole and superior frontal gyrus. Post hoc analyses identified group-level differences between former professional players and unexposed asymptomatic controls in the hippocampus, amygdala, entorhinal cortex, parahippocampal gyrus, insula and superior frontal gyrus. Former college players showed significant volume reductions in the hippocampus, amygdala and superior frontal gyrus compared to the unexposed asymptomatic controls. We did not observe Age × Group interactions for brain morphometric measures. Interactions between morphometry and exposure measures were limited to a single significant positive association between the age of first exposure to organized tackle football and right insular volume. We found no significant relationship between brain morphometric measures and the TES diagnosis core clinical features and provisional level of certainty for CTE pathology outcomes. These findings suggested that MRI morphometrics detect abnormalities in individuals with a history of repetitive head impact exposure that resemble the anatomic distribution of pathological findings from post-mortem CTE studies. The lack of findings associating MRI measures with exposure metrics (except for one significant relationship) or TES diagnosis and core clinical features suggested that brain morphometry must be complemented by other types of measures to characterize individuals with repetitive head impacts.
An investigation for phylogenetic characterization of human Pancreatic cancer microbiome by 16SrDNA Sequencing and Bioinformatics techniques
Hunter, Colby, Dia, Khadimou, Boykins, Julia, Perry, Karrington, Banerjee, Narendra , Cuffee, Jazmine, Armstrong, Erik, Banerjee, Hirendra Nath, Banerjee, Anasua , Morgan, Gabrielle, Banerjee, Hirendra Nath, Bhattacharya, Santanu

No container title available | March 25, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-4140368/v1 | PMID 38585738 Get It

Abstract Pancreatic cancer is a significant public health concern, with increasing incidence rates and limited treatment options. Recent studies have highlighted the role of the human microbiome, particularly the gut microbiota, in the development and progression of this disease. Microbial dysbiosis, characterized by alterations in the composition and function of the gut microbiota, has been implicated in pancreatic carcinogenesis through mechanisms involving chronic inflammation, immune dysregulation, and metabolic disturbances. Researchers have identified specific microbial signatures associated with pancreatic cancer, offering potential biomarkers for early detection and prognostication. By leveraging advanced sequencing and bioinformatics tools, scientists have delineated differences in the gut microbiota between pancreatic cancer patients and healthy individuals, providing insights into disease pathogenesis and potential diagnostic strategies. Moreover, the microbiome holds promise as a therapeutic target in pancreatic cancer treatment. Interventions aimed at modulating the microbiome, such as probiotics, prebiotics, and fecal microbiota transplantation, have demonstrated potential in enhancing the efficacy of existing cancer therapies, including chemotherapy and immunotherapy. These approaches can influence immune responses, alter tumor microenvironments, and sensitize tumors to treatment, offering new avenues for improving patient outcomes and overcoming therapeutic resistance. Overall, understanding the complex interplay between the microbiome and pancreatic cancer is crucial for advancing our knowledge of disease mechanisms and identifying innovative therapeutic strategies. Here we report phylogenetic analysis of the 16S microbial sequences of the pancreatic cancer mice microbiome and corresponding age matched healthy mice microbiome. We successfully identified differentially abundance of microbiota in the pancreatic cancer.
Differences in Donor Heart Acceptance by Race and Gender of Patients on the Transplant Waiting List
Breathett, Khadijah , Mohammed, Selma F. , Mazimba, Sula , Hicks, Albert, Morris, Alanna A. , Colvin, Monica , Daly, Richard C. , Dunlay, Shannon M. , Breathett, Khadijah , Colvin, Monica M , Knapp, Shannon M , Lewsey, Sabra C , Ilonze, Onyedika John , Tedford, Ryan J.

JAMA | March 25, 2024 | Volume: 331 | Issue: 16 | Pages: 1379

10.1001/jama.2024.0065 | PMID 38526480 Get It

ImportanceBarriers to heart transplant must be overcome prior to listing. It is unclear why Black men and women remain less likely to receive a heart transplant after listing than White men and women.ObjectiveTo evaluate whether race or gender of a heart transplant candidate (ie, patient on the transplant waiting list) is associated with the probability of a donor heart being accepted by the transplant center team with each offer.Design, Setting, and ParticipantsThis cohort study used the United Network for Organ Sharing datasets to identify organ acceptance with each offer for US non-Hispanic Black (hereafter, Black) and non-Hispanic White (hereafter, White) adults listed for heart transplant from October 18, 2018, through March 31, 2023.ExposuresBlack or White race and gender (men, women) of a heart transplant candidate.Main Outcomes and MeasuresThe main outcome was heart offer acceptance by the transplant center team. The number of offers to acceptance was assessed using discrete time-to-event analyses, nonparametrically (stratified by race and gender) and parametrically. The hazard probability of offer acceptance for each offer was modeled using generalized linear mixed models adjusted for candidate-, donor-, and offer-level variables.ResultsAmong 159 177 heart offers with 13 760 donors, there were 14 890 candidates listed for heart transplant; 30.9% were Black, 69.1% were White, 73.6% were men, and 26.4% were women. The cumulative incidence of offer acceptance was highest for White women followed by Black women, White men, and Black men (P &amp;lt; .001). Odds of acceptance were less for Black candidates than for White candidates for the first offer (odds ratio [OR], 0.76; 95% CI, 0.69-0.84) through the 16th offer. Odds of acceptance were higher for women than for men for the first offer (OR, 1.53; 95% CI, 1.39-1.68) through the sixth offer and were lower for the 10th through 31st offers.Conclusions and RelevanceThe cumulative incidence of heart offer acceptance by a transplant center team was consistently lower for Black candidates than for White candidates of the same gender and higher for women than for men. These disparities persisted after adjusting for candidate-, donor-, and offer-level variables, possibly suggesting racial and gender bias in the decision-making process. Further investigation of site-level decision-making may reveal strategies for equitable donor heart acceptance.
Improving Trends in Brain Health Explain Declining Dementia Risk?
Vemuri, Prashanthi

JAMA Neurology | March 25, 2024 | Volume: 81 | Issue: 5 | Pages: 442

10.1001/jamaneurol.2024.0476 | PMID 38526457 Get It

Program Directors’ Perspectives on Residency Applications in the Post‒United States Medical Licensing Examination Step 1 Era: A Case for Standardized Letters of Recommendation?
Johny, Angeline, Chisholm, Leah , Riggs, Steve, Jackman, Stephen V. , Khan, Aqsa , Kolettis, Peter N., McNeil, Brian K. , Mayer, Wesley A. , Green, Charles E. , Khan, Aqsa A, Shenot, Patrick J. , Green, Charles

Urology Practice | March 25, 2024 | Volume: 11 | Issue: 3 | Pages: 577-584

10.1097/upj.0000000000000556 | PMID 38526424 Get It